Fig. 1 | British Journal of Cancer

Fig. 1

From: Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study

Fig. 1

Distribution of the CDA activity values. The CDA activity values showed a Gaussian/normal distribution among the NSCLC patients enrolled in the present study. Statistical analysis was performed with the one sample Kolmogorov–Smirnov test, also called the Kolmogorov–Smirnov goodness-of-fit test, showing that this distribution passed the normality test (alpha = 0.05) with a P = 0.20, while skewness and kurtosis were 1.124 and 2.237, respectively. The dashed and pointed lines indicate the two cut-offs (CDA median value and optimal cut-off, respectively)

Back to article page